On Invalid Date, Achilles Therapeutics (NASDAQ: ACHL) reported Q3 2023 earnings per share (EPS) of -$0.42, up 31.25% year over year. Total Achilles Therapeutics earnings for the quarter were -$16.68 million. In the same quarter last year, Achilles Therapeutics's earnings per share (EPS) was -$0.32.
As of Q1 2024, Achilles Therapeutics's earnings has grown year over year. Achilles Therapeutics's earnings in the past year totalled -$75.09 million.
What is ACHL's earnings date?
Achilles Therapeutics's earnings date is Invalid Date. Add ACHL to your watchlist to be reminded of ACHL's next earnings announcement.
What was ACHL's revenue last quarter?
On Invalid Date, Achilles Therapeutics (NASDAQ: ACHL) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Achilles Therapeutics's revenue was $0.00.
What was ACHL's revenue growth in the past year?
As of Q1 2024, Achilles Therapeutics's revenue has grown null year over year. Achilles Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.